Furthermore, combining TUG1 ASO treatment with the alkylating agent TMZ, a first-line treatment for the most common lethal brain tumor, glioblastoma47, synergistically enhances anti-tumor effects on glioblastoma cells. Here, TUG1 is linked to neoplasm.